trial · primary record
Zanubrutinib
CLL (Chronic Lymphocytic Leukemia)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2031-01-01 |
| Primary endpoint | Progression-free survival (PFS) |
| Registry ID | NCT07899398 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:38.048Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07899398
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.